Trials / Conditions / Bowel Diseases, Inflammatory

Bowel Diseases, Inflammatory

10 registered clinical trials studyying Bowel Diseases, Inflammatory — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Use of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults NCT07434310	Dr. Naveed Siddiqui	Phase 3
Completed	LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19 NCT05043363	Imperial College London	—
Completed	Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects NCT04587713	Theravance Biopharma	Phase 1
Terminated	Tofacitinib Registry of Patients With Ulcerative Colitis in Germany NCT04032756	Ced Service GmbH	—
Completed	TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects NCT03408470	Theravance Biopharma	Phase 1
Unknown	Anemia in Inflammatory Bowel Disease NCT02760940	Federal University of Juiz de Fora	Phase 4
Completed	Anti-TNF Therapy for Refractory Colitis in Hospitalized Children NCT02799615	Children's Hospital Medical Center, Cincinnati	—
Terminated	Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD NCT02255227	Centre Hospitalier Universitaire de Saint Etienne	Phase 2
Completed	Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel Disease NCT03999294	University of Valencia	N/A
Completed	Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole NCT00640809	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4